BDNF Levels and Cognitive Function in Patients with Type 2 Diabetes Treated with SGLT2 Inhibitors
Objective: As cognitive impairment becoming more widely recognized as a complication of type 2 diabetes mellitus (T2DM), it is discussed in the literature that antihyperglycemic treatment may also improve cognitive functions. Clinical research on this topic is particularly limited regarding sodium-g...
Saved in:
Main Authors: | Betül SÜMBÜL ŞEKERCİ, Şeymanur DEMİRHAN, Esra ÇALIŞICI, Abdüsselam ŞEKERCİ |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2025-01-01
|
Series: | Bezmiâlem Science |
Subjects: | |
Online Access: | https://www.bezmialemscience.org/articles/bdnf-levels-and-cognitive-function-in-patients-with-type-2-diabetes-treated-with-sglt2-inhibitors/doi/bas.galenos.2024.38268 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brain‐Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta‐Analysis
by: Fatemeh Hasani, et al.
Published: (2025-01-01) -
Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
by: Kyoung Hwa Ha, et al.
Published: (2025-02-01) -
Research Progress of SGLT2 Inhibitors in Cancer Treatment
by: Miao X, et al.
Published: (2025-01-01) -
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
by: Michele Maremmani, et al.
Published: (2025-01-01) -
Effects of early neonatal proinflammatory stress on the expression of BDNF transcripts in the brain regions of prepubertal male rats
by: D. I. Peregud, et al.
Published: (2016-05-01)